BioSyent Inc. (OTCMKTS:BIOYF) Short Interest Down 56.4% in February

BioSyent Inc. (OTCMKTS:BIOYF) was the target of a significant decline in short interest in February. As of February 15th, there was short interest totalling 1,700 shares, a decline of 56.4% from the January 31st total of 3,900 shares. Based on an average daily volume of 1,600 shares, the days-to-cover ratio is presently 1.1 days.

BioSyent Stock Up 0.7 %

BIOYF stock traded up $0.06 during midday trading on Friday, reaching $7.77. The company had a trading volume of 686 shares, compared to its average volume of 3,836. The stock has a 50 day moving average price of $7.75 and a 200-day moving average price of $7.89. BioSyent has a 1-year low of $5.93 and a 1-year high of $8.90.

BioSyent Increases Dividend

The firm also recently announced a dividend, which will be paid on Friday, March 14th. Shareholders of record on Monday, March 3rd will be paid a dividend of $0.0347 per share. This is an increase from BioSyent’s previous dividend of $0.03. The ex-dividend date of this dividend is Friday, February 28th. This represents a yield of 1.77%.

BioSyent Company Profile

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.